Search research articles
Contact Us
Filters
Showing results (61-70 of 139) with videos related to
Page
of 14
Sort By:
The American Journal of the Medical Sciences
|
July 1, 1977
Case report: splenectomy in patients with Hodgkin's disease and marrow hypoplasia
M A Fialk, M Coleman, M D Grant, et al.
Leukemia
|
December 13, 2003
Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study
M Michallet, F Maloisel, M Delain, et al.
Medical and Pediatric Oncology
|
January 1, 1983
Administration of a complex chemotherapy regimen: inpatient versus outpatient treatment
M W Pasmantier, M Coleman, R T Silver, et al.
Leukemia
|
July 1, 1991
Densitometric analysis of Southern blot autoradiographs and its application to monitoring patients with chronic myeloid leukemia
A Grossman, R T Silver, T P Szatroswki, et al.
Canadian Journal of Genetics and Cytology. Journal Canadien De Genetique Et De Cytologie
|
December 1, 1986
Role of heterochromatin during preferential 9q;22q translocation in chronic myelogenous leukemia
R S Verma, J Rodriguez, A Babu, et al.
Cancer Treatment Reports
|
May 1, 1985
Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients
M W Pasmantier, M Coleman, R T Silver, et al.
Journal of Cancer Research and Clinical Oncology
|
September 10, 1999
Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer
G T Budd, J Atiba, R T Silver, et al.
American Journal of Human Genetics
|
November 1, 1989
Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia
A Grossman, R T Silver, Z Arlin, et al.
Blood
|
September 25, 1998
A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia
I Buño, W A Wyatt, A R Zinsmeister, et al.
Cancer Chemotherapy Reports
|
May 11, 1975
Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208)
R A Kyle, B R Seligman, H J Wallace, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 139) with videos related to
Sort By:
Page
of 14
The American Journal of the Medical Sciences
|
July 1, 1977
Case report: splenectomy in patients with Hodgkin's disease and marrow hypoplasia
M A Fialk, M Coleman, M D Grant, et al.
Leukemia
|
December 13, 2003
Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study
M Michallet, F Maloisel, M Delain, et al.
Medical and Pediatric Oncology
|
January 1, 1983
Administration of a complex chemotherapy regimen: inpatient versus outpatient treatment
M W Pasmantier, M Coleman, R T Silver, et al.
Leukemia
|
July 1, 1991
Densitometric analysis of Southern blot autoradiographs and its application to monitoring patients with chronic myeloid leukemia
A Grossman, R T Silver, T P Szatroswki, et al.
Canadian Journal of Genetics and Cytology. Journal Canadien De Genetique Et De Cytologie
|
December 1, 1986
Role of heterochromatin during preferential 9q;22q translocation in chronic myelogenous leukemia
R S Verma, J Rodriguez, A Babu, et al.
Cancer Treatment Reports
|
May 1, 1985
Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients
M W Pasmantier, M Coleman, R T Silver, et al.
Journal of Cancer Research and Clinical Oncology
|
September 10, 1999
Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer
G T Budd, J Atiba, R T Silver, et al.
American Journal of Human Genetics
|
November 1, 1989
Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia
A Grossman, R T Silver, Z Arlin, et al.
Blood
|
September 25, 1998
A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia
I Buño, W A Wyatt, A R Zinsmeister, et al.
Cancer Chemotherapy Reports
|
May 11, 1975
Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208)
R A Kyle, B R Seligman, H J Wallace, et al.
Page
of 14